SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001099910-24-000039
Filing Date
2024-01-18
Accepted
2024-01-18 14:12:22
Documents
13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT akan_f3.htm F-3 299837
2 FORM OF HALO COLLECTIVE INC. PROMISSORY NOTE ex4-3.htm EX-4.3 9278
3 FORM OF STANDARD PROMISSORY NOTE ex4-4.htm EX-4.4 75930
4 OPINION OF GOWLING WLG (CANADA) LLP ex5-1.htm EX-5.1 40130
5 CONSENT OF RIMON, P.C. ex23-2.htm EX-23.2 4323
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-3.htm EX-23.3 3825
7 CONSENT OF INDEPENDENT ACCOUNTANTS ex23-4.htm EX-23.4 4351
8 FILING FEES exfilingfees.htm EX-FILING FEES 32462
9 GRAPHIC image_001.jpg GRAPHIC 13609
10 GRAPHIC image_002.jpg GRAPHIC 16236
11 GRAPHIC image_04.jpg GRAPHIC 9193
12 GRAPHIC image_03.jpg GRAPHIC 2547
13 GRAPHIC image_05.jpg GRAPHIC 2882
  Complete submission text file 0001099910-24-000039.txt   533111
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-276577 | Film No.: 24541281
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)